Journal Article Summary
The article discusses a case involving an 11-year-old girl who experienced severe drowsiness after taking clobazam, a medication used to treat epilepsy. This situation is significant because it highlights the potential for adverse reactions to medications, particularly in children, and raises awareness about how genetic factors can influence drug metabolism. Understanding these reactions is crucial for ensuring safe and effective treatment for patients with epilepsy.
The authors examined the girl's case, noting that her hypersomnolence occurred after just one week of clobazam treatment. They ruled out drug interactions as a cause and instead focused on her genetic makeup, specifically a variant in the CYP2C19 gene that affects how her body metabolizes the medication. The genetic analysis revealed that she had a poor metabolizer genotype, which likely contributed to her adverse reaction. This finding suggests that genetic testing could be beneficial in identifying patients at risk for similar side effects when prescribed clobazam.
However, the study has limitations, including the fact that genetic testing for all patients on clobazam is not currently feasible in clinical practice. This raises concerns about patient safety, as undiagnosed genetic variations can lead to unexpected drug responses. Patients and caregivers should discuss any unusual side effects experienced during treatment with a healthcare professional, as this could indicate the need for further evaluation or adjustments in medication.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Hamilton Katherine E., Shelton Chasity M., Wheless James, Phelps Stephanie J.. Persistent Hypersomnolence Following Clobazam in a Child With Epilepsy and Undiagnosed CYP2C19 Polymorphism. The Journal of Pediatric Pharmacology and Therapeutics : JPPT 2020. DOI: 10.5863/1551-6776-25.4.320. PMID: 32461746. PMCID: PMC7243903.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
